Hepatic clearance models and IVIVE predictions
- PMID: 35234281
- DOI: 10.1002/cpt.2525
Hepatic clearance models and IVIVE predictions
Comment on
-
Can In Vitro-In Vivo Extrapolation Be Successful? Recognizing the Incorrect Clearance Assumptions.Clin Pharmacol Ther. 2022 May;111(5):1022-1035. doi: 10.1002/cpt.2482. Epub 2021 Dec 8. Clin Pharmacol Ther. 2022. PMID: 34731496 Free PMC article. Review.
References
-
- Benet, L.Z. & Sodhi, J.K. Can in vitro-in vivo extrapolation (IVIVE) be successful? Recognizing the incorrect clearance assumptions. Clin. Pharmacol. Ther. 111, 1022-1035 (2022).
-
- Marchionni, N. et al. Age related changes in the pharmacodynamics of intravenous glyceryl trinitrate. Aging 2, 59-64 (1990).
-
- Rowland, M. Influence of route of administration on drug availability. J. Pharm. Sci. 61, 70-74 (1972).
-
- Benet, L.Z., Sodhi, J.K., Makrygiorgos, G. & Mesbah, A. There is only one valid definition of clearance: Critical examination of clearance concepts reveals the potential for errors in clinical drug dosing decisions. AAPS J. 23, 67 (2021).
-
- Pang, K.S., Han, Y.R., Noh, K., Lee, P.I. & Rowland, M. Commentary: Hepatic clearance concepts and misconceptions: Why the well-stirred model is still used even though it is not physiologic reality? Biochem. Pharmacol. 169, 113596 (2019).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources